Bio-Techne Corp

TECH: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
^%vLOCK|GQ^TLOCK|>mGXsf%b

Bio-Techne: Acquisition by Merck KGaA Still on Track For Late 2026 or Early 2027 Close

Bio-Techne's acquisition by Merck KGaA, announced June 25, 2026, remains on track to close by late 2026 or early 2027. After clearing Germany's antitrust review on Aug. 17 and US antitrust review on Sept. 18, Bio-Techne shareholders approved the merger on Sept. 23.

Sponsor Center